{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:31:56Z","timestamp":1781015516760,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jsat.2013.10.006","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T20:48:23Z","timestamp":1381783703000},"page":"291-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["From methadone to buprenorphine: Changes during a 10 year period within a national opioid maintenance treatment programme"],"prefix":"10.1016","volume":"46","author":[{"given":"Marianne","family":"Riksheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gossop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2013.10.006_bb0185","author":"ABS"},{"key":"10.1016\/j.jsat.2013.10.006_bb0010","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10550490490440780","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"The American Journal on Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0015","series-title":"The effectiveness of methadone maintenance treatment: Patients, programs, services, and outcome","author":"Ball","year":"1991"},{"key":"10.1016\/j.jsat.2013.10.006_bb0020","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09595230412331289473","article-title":"A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence","volume":"23","author":"Bell","year":"2004","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.jsat.2013.10.006_bb0025","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","article-title":"Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention","volume":"104","author":"Burns","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","article-title":"Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study","volume":"94","author":"Clausen","year":"2008","journal-title":"Drug Alcohol Dependence"},{"key":"10.1016\/j.jsat.2013.10.006_bb0035","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1360-0443.2009.02570.x","article-title":"Mortality among opiate users: Opioid maintenance therapy, age and causes of death","volume":"104","author":"Clausen","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c5475","article-title":"Risk of death during and after opiate substitution treatment in primary care: Prospective observational study in UK General Practice Research Database","volume":"341","author":"Cornish","year":"2010","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jsat.2013.10.006_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta\u2010analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0190","series-title":"Annual report on the state of the drugs problem in Europe","author":"EMCDDA","year":"2012"},{"key":"10.1016\/j.jsat.2013.10.006_bb0055","unstructured":"EMCDDA. (2012b). Estimated number of clients in methadone treatment and of all clients receiving any opioid substitution treatment (OST). Statistical bulletin 2012 - Table HSR-3."},{"key":"10.1016\/j.jsat.2013.10.006_bb0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5324\/nje.v21i1.1434","article-title":"Variations in treatment organisation, practices and outcomes within the Norwegian Opioid Maintenance Treatment Programme","volume":"21","author":"Gjersing","year":"2011","journal-title":"Norsk Epidemiologi"},{"key":"10.1016\/j.jsat.2013.10.006_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.drugalcdep.2007.03.010","article-title":"Implementation of buprenorphine in the Veterans Health Administration: Results of the first 3years","volume":"90","author":"Gordon","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2013.10.006_bb0195","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1360-0443.1991.tb01883.x","article-title":"A six country survey of the content and structure of heroin treatment programmes using methadone","volume":"86","author":"Gossop","year":"1991","journal-title":"British Journal Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0075","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2013.10.006_bb0080","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jsat.2013.10.006_bb0085","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1176\/ajp.2007.164.5.797","article-title":"A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial","volume":"164","author":"Kakko","year":"2007","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2013.10.006_bb0090","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0095","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2013.10.006_bb0200","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2307\/1907187","article-title":"Nonparametric tests against trend","author":"Mann","year":"1945","journal-title":"Econometrica: Journal of the Econometric Society"},{"key":"10.1016\/j.jsat.2013.10.006_bb0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","article-title":"The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta\u2010analysis","volume":"93","author":"Marsch","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0110","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2013.10.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2013.10.006_bb0120","series-title":"The Norwegian Directorate of Health - Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet","author":"NDH","year":"2010"},{"key":"10.1016\/j.jsat.2013.10.006_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","article-title":"Buprenorphine: A controlled clinical trial in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2013.10.006_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(00)00163-0","article-title":"Double-blind randomized trial of buprenorphine and methadone in opiate dependence","volume":"62","author":"Petitjean","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2013.10.006_bb0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT Trial: A field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2013.10.006_bb0140","unstructured":"R. (2012). A Language and Environment (Version 2.15.0): R Development Core Team."},{"key":"10.1016\/j.jsat.2013.10.006_bb0145","unstructured":"SAMHSA. (2005). National Survey of Substance Abuse Treatment Services (N-SSATS): 2005 - Data on Substance Abuse Treatment Facilities: Substance Abuse and Mental Health Services Administration."},{"key":"10.1016\/j.jsat.2013.10.006_bb0150","unstructured":"SAMHSA. (2011). National Survey of Substance Abuse Treatment Services (N-SSATS): 2011 - Data on Substance Abuse Treatment Facilities: Substance Abuse and Mental Health Services Administration."},{"key":"10.1016\/j.jsat.2013.10.006_bb0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/145507251002700604","article-title":"Shifting focus in substitution treatment in the Nordic countries","volume":"27","author":"Skretting","year":"2010","journal-title":"Nordic Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2013.10.006_bb0160","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jsat.2013.10.006_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000019022","article-title":"Variation between and within drug treatment modalities: Data from the National Treatment Outcome Research Study (UK)","volume":"6","author":"Stewart","year":"2000","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2013.10.006_bb0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1360-0443.2007.01762.x","article-title":"Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995\u20132005","volume":"102","author":"Strang","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2013.10.006_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jsat.2006.03.007","article-title":"Multimodal drug addiction treatment: A field comparison of methadone and buprenorphine among heroin-and cocaine-dependent patients","volume":"31","author":"Vigezzi","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2013.10.006_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000097935","article-title":"Merits and problems in high-threshold methadone maintenance treatment","volume":"13","author":"Waal","year":"2007","journal-title":"European Addiction Research"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547213002407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547213002407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:39:44Z","timestamp":1760038784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547213002407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0740547213002407"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2013.10.006","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From methadone to buprenorphine: Changes during a 10year period within a national opioid maintenance treatment programme","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2013.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}